These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1647798)

  • 1. What is the role of the central nervous system in mineralocorticoid hypertension?
    Gómez Sánchez EP
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):374-81. PubMed ID: 1647798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension.
    Gómez-Sánchez EP; Fort CM; Gómez-Sánchez CE
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E482-4. PubMed ID: 2316642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats.
    Gomez-Sanchez EP; Fort C; Thwaites D
    Am J Physiol; 1992 Jan; 262(1 Pt 1):E96-9. PubMed ID: 1310219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats.
    Huang BS; White RA; Jeng AY; Leenen FH
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R994-R1000. PubMed ID: 19118098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension.
    Gómez-Sánchez EP; Venkataraman MT; Thwaites D; Fort C
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E649-53. PubMed ID: 2333961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralocorticoids, salt and high blood pressure.
    Gómez-Sánchez EP; Zhou M; Gomez-Sanchez CE
    Steroids; 1996 Apr; 61(4):184-8. PubMed ID: 8732997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 3beta-hydroxysteroid dehydrogenase inhibition by trilostane on blood pressure in the Dahl salt-sensitive rat.
    Gomez-Sanchez EP; Samuel J; Vergara G; Ahmad N
    Am J Physiol Regul Integr Comp Physiol; 2005 Feb; 288(2):R389-93. PubMed ID: 15458970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptors and hypertension.
    Funder JW
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):53-5. PubMed ID: 7626506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of mineralocorticoid action in the brain in salt-sensitive hypertension.
    Oki K; Gomez-Sanchez EP; Gomez-Sanchez CE
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):90-5. PubMed ID: 21585422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
    van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
    Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone.
    Gomez-Sanchez EP; Gomez-Sanchez CE
    Am J Physiol; 1992 Dec; 263(6):E1125-30. PubMed ID: 1476186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebroventricular infusion of aldosterone induces hypertension in rats.
    Gomez-Sanchez EP
    Endocrinology; 1986 Feb; 118(2):819-23. PubMed ID: 3943493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of central mineralocorticoid binding sites in development of hypertension.
    Janiak PC; Lewis SJ; Brody MJ
    Am J Physiol; 1990 Nov; 259(5 Pt 2):R1025-34. PubMed ID: 2240262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of brain corticosterone and aldosterone in central angiotensin II-induced hypertension.
    Huang BS; White RA; Ahmad M; Leenen FH
    Hypertension; 2013 Sep; 62(3):564-71. PubMed ID: 23856493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of central amiloride infusion on mineralocorticoid hypertension.
    Gomez-Sanchez EP; Gomez-Sanchez CE
    Am J Physiol; 1994 Nov; 267(5 Pt 1):E754-8. PubMed ID: 7977727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone, salt and cardiac fibrosis.
    Funder JW
    Clin Exp Hypertens; 1997; 19(5-6):885-99. PubMed ID: 9247762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central infusion of aldosterone synthase inhibitor prevents sympathetic hyperactivity and hypertension by central Na+ in Wistar rats.
    Huang BS; White RA; Ahmad M; Jeng AY; Leenen FH
    Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R166-72. PubMed ID: 18495825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The amygdala: site of genomic and nongenomic arousal of aldosterone-induced sodium intake.
    Sakai RR; McEwen BS; Fluharty SJ; Ma LY
    Kidney Int; 2000 Apr; 57(4):1337-45. PubMed ID: 10760064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brain mineralocorticoid receptor and blood pressure control in the conscious normotensive rat].
    Rahmouni K; Barthelmebs M; Imbs JL; De Jong W
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1009-12. PubMed ID: 9749155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension.
    Gomez-Sanchez EP; Gomez-Sanchez CM; Plonczynski M; Gomez-Sanchez CE
    Exp Physiol; 2010 Jan; 95(1):120-30. PubMed ID: 19837774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.